Braxia Scientific Corp.
BRAX
CNSX
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | 25.21% | 18.85% | -1.68% | -1.99% | -124.41% |
| Total Depreciation and Amortization | -12.57% | 104.60% | 1,058.27% | 2,180.65% | 2,192.59% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -18.24% | -32.97% | -19.77% | -18.15% | 198.88% |
| Change in Net Operating Assets | 162.30% | -35.07% | -395.45% | -940.43% | -4,991.04% |
| Cash from Operations | 65.72% | -0.22% | -64.18% | -53.81% | -115.75% |
| Capital Expenditure | 92.32% | 86.88% | -92.12% | -3,062.69% | -3,733.12% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -100.00% | -100.00% | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 106.84% | 113.84% | 73.68% | 48.46% | -133.06% |
| Cash from Investing | 98.97% | 102.50% | 25.81% | -80.85% | -374.52% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -250.48% | -133.75% | -161.31% | -144.74% | -125.81% |
| Issuance of Common Stock | -52.16% | -52.16% | -52.16% | -53.44% | 3,519.73% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -57.48% | -56.27% | -56.25% | -57.23% | 3,889.40% |
| Foreign Exchange rate Adjustments | 57.69% | -103.56% | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 78.01% | 4.43% | -149.87% | -179.57% | -66.05% |
